Therefore, Measurement of TIBC upon ICU admission may become the first step towards developing the approach such as hepcidin-targeting therapy or reduction of phlebotomy-associated blood loss to preventing anemia or RBC transfusion in critically ill patients. Here, HAMP is linked to anemia.